Ampio pharmaceuticals to present at the emerging growth conference

Englewood, colo. , sept. 26, 2023 /prnewswire/ -- ampio pharmaceuticals, inc. (nyse american: ampe) (the "company") a pre-revenue stage biopharmaceutical company focused on development of a potential treatment for osteoarthritis as part of its oa.201 program, today announced that its ceo, michael a.
AMPE Ratings Summary
AMPE Quant Ranking